Charles Robb
2019
In 2019, Charles Robb earned a total compensation of $2.6M as Chief Financial Officer and Secretary at Corcept Therapeutics, a 8% decrease compared to previous year.
Compensation breakdown
| Bonus | $308,881 |
|---|---|
| Option Awards | $1,845,345 |
| Salary | $456,133 |
| Total | $2,610,359 |
Robb received $1.8M in option awards, accounting for 71% of the total pay in 2019.
Robb also received $308.9K in bonus and $456.1K in salary.
Rankings
In 2019, Charles Robb's compensation ranked 4,671st out of 13,971 executives tracked by ExecPay. In other words, Robb earned more than 66.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,671 out of 13,971 | 67th |
Division Manufacturing | 1,746 out of 5,701 | 69th |
Major group Chemicals And Allied Products | 610 out of 2,200 | 72nd |
Industry group Drugs | 514 out of 1,886 | 73rd |
Industry Pharmaceutical Preparations | 387 out of 1,398 | 72nd |
Source: SEC filing on April 27, 2020.
Robb's colleagues
We found three more compensation records of executives who worked with Charles Robb at Corcept Therapeutics in 2019.
News
Corcept Therapeutics CEO Joseph Belanoff's 2021 pay jumps 91% to $11M
April 25, 2022
Corcept Therapeutics CEO Joseph Belanoff's 2020 pay rises 16% to $5.8M
April 22, 2021
Corcept Therapeutics CEO Joseph Belanoff's 2019 pay falls 21% to $5M
April 27, 2020
Corcept Therapeutics CEO Joseph Belanoff's 2018 pay jumps 48% to $6.3M
April 24, 2019